Tyra Biosciences Inc (TYRA)
16.43
-0.89
(-5.14%)
USD |
NASDAQ |
May 28, 16:00
16.43
0.00 (0.00%)
After-Hours: 18:41
Tyra Biosciences Total Assets (Quarterly): 404.74M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 404.74M |
| December 31, 2023 | 225.86M |
| September 30, 2023 | 238.36M |
| June 30, 2023 | 250.01M |
| March 31, 2023 | 255.06M |
| December 31, 2022 | 266.18M |
| September 30, 2022 | 275.98M |
| Date | Value |
|---|---|
| June 30, 2022 | 287.12M |
| March 31, 2022 | 298.97M |
| December 31, 2021 | 306.70M |
| September 30, 2021 | 315.97M |
| June 30, 2021 | 139.92M |
| December 31, 2020 | 16.01M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
16.01M
Minimum
Dec 2020
404.74M
Maximum
Mar 2024
252.38M
Average
266.18M
Median
Dec 2022
Total Assets (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 5.357M |
| Palatin Technologies Inc | 11.41M |
| iBio Inc | 50.15M |
| Theriva Biologics Inc | 48.73M |
| Oragenics Inc | 3.534M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 14.86M |
| Shareholders Equity (Quarterly) | 389.88M |